Shares of this Pharma stock under the ‘small-cap’ category are trading in the green after the company is set to turn ex-split next week. In the last month itself, the company’s stock has gained around 20 percent.
With a market capitalization of Rs 1,734.72 crores, the stocks of Themis Medicare Limited started their trading session on Friday at Rs 1,896.95 and currently trades at Rs 1885, gaining around 0.80 percent as compared to the previous closing levels of Rs 1,870.45 apiece.
The company, in a regulatory filing published with the BSE in September end, intimated that the shareholders have approved the sub-division/split in the ratio of 1:10.
The same means that very fully paid-up equity share having a face value of Rs 10 each will be split into 10 fully paid-up equity shares having a face value of Rs 1 each. The Record Date for the same is fixed as 10th October 2023.
During the recent financial quarters, the company reported an increase in its prime business indicators such as operating revenues and after-tax profits. The operating revenues grew from Rs 80.1 crores during Q4FY22-23 to Rs 96.65 crores during Q1FY23-24, and, the latter, during the same period, moving up from Rs 6.04 crores to Rs 12.55 crores.
Due to sector-specific reasons and increasing input costs, the company’s net profit margins took a hit and the most recent movement shows a reduction from 18.47 percent during FY21-22 to 16.06 percent during FY22-23.
According to the latest shareholding pattern for the quarter ended June 2023, the company’s Promoters hold a 67.16 percent stake followed by the Retail Investors holding a 32.79 percent stake in the company.
Themis Medicare Limited is a company based in India that is engaged in the business of manufacturing Pharmaceutical products. Some of the products included in its portfolio comprise anti-malarial, nutritional gummies, CCD products, and many more. Geographically, the company derives most of its revenue from international market operations.
Another listed company named Gujarat Themis Biosyn Limited, managed by the Promoters of Themis Medicare Limited, is also going to trade ex-split next week. The split ratio is 1:5 and the Record Date is fixed as 10th October 2023.
Written by Amit Madnani
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
